Clinical trial

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

NCT00101283

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record pemetrexed disodium Normalized identity: pemetrexed disodiumView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record gemcitabine hydrochloride Normalized identity: gemcitabine hydrochlorideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-02-23

PhasePHASE2

Conditions

Mesotheliomaverified · MONDO: mesothelioma

Interventions

pemetrexed disodiumDRUG · verified · RxNorm: pemetrexed disodium

gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride

carboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

Eastern Cooperative Oncology Grouplead sponsor

National Cancer Institute (NCI)collaborator

North Central Cancer Treatment Groupcollaborator

Mapped research locations

PeoriaIllinois, United States5 IndianapolisIndiana, United States3 Saint PaulMinnesota, United States3 Sioux FallsSouth Dakota, United States3 KalamazooMichigan, United States3 South BendIndiana, United States3 DuluthMinnesota, United States3 PhiladelphiaPennsylvania, United States2 MinneapolisMinnesota, United States2 Ann ArborMichigan, United States2 FlintMichigan, United States2 Saint Louis ParkMinnesota, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00101283 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.